ConductScience.org, home

Paper3594486

Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma.

Nelson M and 4 others. Cancer Immunol Immunother, 1987. Cited by 6 papers, by iCite.

Cite this record

ConductScience Library. Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma. Papers, record 3594486. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3594486

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Depression of cell-mediated immunity by tumour cell products: induction of resistance by immunotherapeutically active extracts of bovine ocular squamous cell carcinoma.
PubMed
Journal
Cancer Immunol Immunother
PubMed
Year
1987
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
6
iCite
Relative citation ratio, by iCite
0.25
iCite
Revised in PubMed
2024-04-26
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Nelson MM
2Nelson DSD S
3Kuchroo VKV K
4Spradbrow PBP B
5Jennings PAP A

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Adjuvants, ImmunologicMajor topic
Carcinoma, Squamous CellMajor topic
Eye NeoplasmsMajor topic
Immune ToleranceMajor topic
Immunity, CellularMajor topic
Sarcoma, ExperimentalMajor topic
Animals
Cattle
Humans
Hypersensitivity, Delayed
Immunotherapy
Mice
Rats
Suppressor Factors, Immunologic

Source PubMed

Download CSV of topics

References25

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16227669Suppression of the responsiveness of lymphocytes from cancer patients triggered by co-culture with autologous tumor-derived cells.J Immunol1983https://conductscience.org/library/papers/6227669PubMed
26932528Macrophages and resistance to tumors. IV. Influence of age on susceptibility of mice to anti-inflammatory and antimacrophage effects of tumor cell products.J Natl Cancer Inst1980https://conductscience.org/library/papers/6932528PubMed
3942051A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.Anal Biochem1976https://conductscience.org/library/papers/942051PubMed
46334655The inhibition of lymphocyte stimulation by autologous human metastatic melanoma cells correlates with the expression of HLA-DR antigens on the tumor cells.Int J Cancer1984https://conductscience.org/library/papers/6334655PubMed
5305888Delayed hypersensitivity in mice induced by intravenous sensitization with sheep erythrocytes: evidence for tuberculin type delayed hypersensitivity of the reaction.Immunology1978https://conductscience.org/library/papers/305888PubMed
6627408Macrophages and resistance to tumours. I. Inhibition of delayed-type hypersensitivity reactions by tumour cells and by soluble prducts affecting macrophages.Immunology1978https://conductscience.org/library/papers/627408PubMed
76457595Cancer and subversion of host defences.Aust J Exp Biol Med Sci1981https://conductscience.org/library/papers/6457595PubMed
86815363Characterization of anti-inflammatory factors produced by murine tumor cells in culture.J Natl Cancer Inst1982https://conductscience.org/library/papers/6815363PubMed
96600505Bovine ocular squamous cell carcinoma: tumor-associated immunity detected by E-rosette augmentation test.J Natl Cancer Inst1983https://conductscience.org/library/papers/6600505PubMed
107026615Inhibitors of monocyte responses to chemotaxins are present in human cancerous effusions and react with monoclonal antibodies to the P15(E) structural protein of retroviruses.J Clin Invest1981https://conductscience.org/library/papers/7026615PubMed
112984289Retrovirus-mediated immunosuppression. I. FeLV-UV and specific FeLV proteins alter T lymphocyte behavior by inducing hyporesponsiveness to lymphokines.J Immunol1985https://conductscience.org/library/papers/2984289PubMed
124042416Successful tumour immunotherapy: possible role of antibodies to anti-inflammatory factors produced by neoplasms.Clin Exp Immunol1985https://conductscience.org/library/papers/4042416PubMed
137047385Inhibition of cytokine production by a tumor cell product.Immunology1982https://conductscience.org/library/papers/7047385PubMed
144215075Antiinflammatory effects of murine malignant cells.Proc Natl Acad Sci U S A1974https://conductscience.org/library/papers/4215075PubMed
1567885An evaluation of leukocyte adherence inhibition in the immunodiagnosis of colorectal cancer.Cancer Res1977https://conductscience.org/library/papers/67885PubMed
162987350Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.J Immunol1985https://conductscience.org/library/papers/2987350PubMed
176605993Inhibition of interleukin 2 production by factors released from tumor cells.J Immunol1983https://conductscience.org/library/papers/6605993PubMed
18185294Depression of macrophage function by a factor produced by neoplasms: a merchanism for abrogation of immune surveillance.J Immunol1976https://conductscience.org/library/papers/185294PubMed
196183354
Immunoregulatory factors derived from human tumors. II. Partial purification and further immunobiochemical characterization of a human sarcoma-derived immunosuppressive factor expressing HLA-DR and immunoglobulin-related determinants.
J Immunol1983https://conductscience.org/library/papers/6183354PubMed
2068658Immunosuppression and the role of suppressive factors in cancer.Adv Cancer Res1977https://conductscience.org/library/papers/68658PubMed

See all 25 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.

PMIDTitleJournalYearIn Papers
2598177Effects of CKS-17, a synthetic retroviral envelope peptide, on cell-mediated immunity in vivo: immunosuppression, immunogenicity, and relation to immunosuppressive tumor products.Cancer Immunol Immunother1989https://conductscience.org/library/papers/2598177

Source PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3594486

GET https://conductscience.org/api/papers/v1/3594486/references?page=2